FindTrial
Sign In

The optimal target for acute glycemic control in critically ill patients: update systematic review

The optimal target for acute glycemic control in critically ill patients: update systematic review - The optimal target for acute glycemic control in critically ill patients: update systematic review

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000049483
Enrollment
Unknown
Registered
2022-11-12
Start date
2022-11-12
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critically ill patients.

Interventions

None listed

Sponsors

Guideline committee of The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Randomized controlled trials. 2) Adult patients who were treated in the Intensive Care Unit. 3) One of the following blood glucose targets: <110, 110-144, 144-180, >180 (mg/dL) vs One of the other targets other than the target included in intervention 4) Japanese or English

Exclusion criteria

Exclusion criteria: Conference abstract

Design outcomes

Primary

MeasureTime frame
Long-term mortality (more than 60 days), 28 or 30 days mortality, and in-hospital mortality.—

Secondary

MeasureTime frame
Incidences of hypoglycemia (defined as blood glucose levels of <40 mg/dL or hypoglycemia-associated symptoms), sepsis and bloodstream infection.—

Countries

Japan

Contacts

Public ContactTomoaki Yatabe

Nishichita General Hospital Emergency Department

yatabe.tomoaki@katch.ne.jp0562335500

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026